06 Jun 2017 --- A recent randomized controlled clinical trial has shown that Indena’s bioavailable curcumin formulation, Meriva, may improve the health status in subjects with non-alcoholic fatty liver disease (NAFLD), as assessed by multiple liver parameters. This is the first clinical study investigating the effects, efficacy and safety of curcumin phytosome supplementation in fatty liver disorders, Indena reports.
